LoginRegister
    Novo Nordisk Tresiba shows lower risk of hypo in adults with Type 2 DiabetesNovo Nordisk Tresiba shows lower risk of hypo in adults with Type 2 Diabetes
    Brexit freight plans needed urgently, says drug, medical suppliersBrexit freight plans needed urgently, says drug, medical suppliers
    Biocon Chief Kiran Shaw, FM Nirmala Sitharaman in tiff over E-Cigarette banBiocon Chief Kiran Shaw, FM Nirmala Sitharaman in tiff over E-Cigarette ban
    No cancer causing impurities found in BP drug Valsartan during initial approval process, says DCGINo cancer causing impurities found in BP drug Valsartan during initial approval process, says DCGI
    Upcoming Pharma City project to generate Rs 64000 crore investments: Minister informs Telangana assemblyUpcoming Pharma City project to generate Rs 64000 crore investments: Minister informs Telangana...
    Novartis combination therapy with Vildagliptin-Metformin shows positive results for Type 2 DiabetesNovartis combination therapy with Vildagliptin-Metformin shows positive results for Type 2 Diabetes
    Merck Ebola Vaccine V920 up for USFDA reviewMerck Ebola Vaccine V920 up for USFDA review
    GSK fights bid to strike new Zofran preemption evidenceGSK fights bid to strike new Zofran preemption evidence
    Police protection for Drug Regulators, Inspectors, recommends CDSCO committeePolice protection for Drug Regulators, Inspectors, recommends CDSCO committee
    Lupin gets USFDA warning letter for Mandideep Unit-1 facilityLupin gets USFDA warning letter for Mandideep Unit-1 facility
    Twin Approvals: Abbott bags CE Mark for its Mechanical Heart Valve and Occluder devicesTwin Approvals: Abbott bags CE Mark for its Mechanical Heart Valve and Occluder devices
    Mylan launches generic version of Faslodex Injection to treat breast cancerMylan launches generic version of Faslodex Injection to treat breast cancer
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X